Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 365,000 | 613,000 | 447,000 | 467,000 |
| Receivables | 0 | 513,000 | 478,000 | 441,000 | 394,000 |
| Inventories | 0 | 445,000 | 429,000 | 477,000 | 513,000 |
| Other current assets | 0 | 201,000 | 184,000 | 225,000 | 317,000 |
| TOTAL | $0 | $1,524,000 | $1,704,000 | $1,590,000 | $1,691,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | 8,884,000 | 8,929,000 | 9,485,000 | 9,719,000 |
| Investments And Advances | 0 | 123,000 | 154,000 | 150,000 | 149,000 |
| Intangibles | 0 | 811,000 | 821,000 | 857,000 | 862,000 |
| Other Non-Current Assets | 0 | 429,000 | 399,000 | 677,000 | 659,000 |
| TOTAL | $N/A | $10,247,000 | $10,303,000 | $11,169,000 | $11,389,000 |
| Total Assets | $0 | $11,771,000 | $12,007,000 | $12,759,000 | $13,080,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 105,000 | 99,000 | 106,000 | 117,000 |
| Accounts payable and accrued liabilities | 0 | 367,000 | 288,000 | 370,000 | 287,000 |
| Accrued Expenses | 0 | 288,000 | 347,000 | 270,000 | 342,000 |
| Other current liabilities | 0 | 60,000 | 75,000 | 84,000 | 92,000 |
| TOTAL | $0 | $1,049,000 | $867,000 | $903,000 | $904,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 8,328,000 | 8,648,000 | 9,211,000 | 9,200,000 |
| Other Non-Current Liabilities | 0 | 496,000 | 491,000 | 496,000 | 520,000 |
| TOTAL | $N/A | $8,829,000 | $9,156,000 | $9,737,000 | $9,754,000 |
| Total Liabilities | $0 | $9,878,000 | $10,023,000 | $10,640,000 | $10,658,000 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 0 | -1,851,000 | -1,758,000 | -1,626,000 | -1,330,000 |
| Other shareholders' equity | 0 | 24,000 | 421,000 | 424,000 | 430,000 |
| TOTAL | $0 | $1,893,000 | $1,984,000 | $2,119,000 | $2,422,000 |
| Total Liabilities And Equity | $0 | $11,771,000 | $12,007,000 | $12,759,000 | $13,080,000 |